MBS MEDICAL SYSTEMS LTD

Executive Summary

MBS MEDICAL SYSTEMS LTD is an active private limited company classified as micro-entity but shows no financial activity or operational assets. The zero net assets and lack of cash flow present a high credit risk with no current ability to service debt or commercial obligations. Credit facilities are not recommended until evidence of trading and financial improvement is demonstrated.

MBS MEDICAL SYSTEMS LTD - Analysis Report

Company Number: 13531653

Analysis Date: 2025-07-29 20:50 UTC

1. Credit Opinion: DECLINE
   MBS MEDICAL SYSTEMS LTD shows no financial substance or trading activity in its filed accounts for the past three years. The balance sheet reveals zero net assets, zero liabilities, and no working capital, indicating no operational business or revenue generation. The absence of employees and lack of fixed or current assets suggests the company is dormant or non-trading despite being active on the register. There is no evidence of cash flow or profitability to support servicing of debt facilities or commercial commitments. This presents a high credit risk with no visible capacity to meet financial obligations.

2. Financial Strength:
   The company’s financial position is effectively nil. The micro-entity balance sheet as of 31 July 2024 shows total assets less current liabilities at £0, with no equity capital or reserves. Current liabilities are zero, but so are current assets, resulting in zero net current assets and zero shareholders' funds. No fixed assets or cash balances are reported. This indicates no financial buffer or capital base to absorb losses or leverage for growth.

3. Cash Flow Assessment:
   No cash or working capital is reported, and no operating activity is evident. The company has no employees and no accrued income or prepayments, pointing to an absence of trading operations. This lack of liquidity means the company cannot meet any short-term financial commitments or support debt repayments. Without cash inflows, the business is not viable as a credit risk.

4. Monitoring Points:

• Filing of more detailed accounts or management accounts to evidence trading activity or financial improvement.
• Changes in asset base or introduction of working capital.
• Appointment of additional directors or key management that could bring operational expertise.
• Any related party transactions or funding injections that improve liquidity.
• Monitoring for overdue filings or signs of insolvency proceedings.